Invitation to presentation of Xbrane Biopharma’s interim report January – June 2025 on August 26, 2025

Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Tuesday, August 26th, 2025, at 09.00 a.m. CET. Xbrane will publish the company’s interim report January – June 2025, on Tuesday, August 26, 2025, at 8.00 a.m. CET.

Martin Åmark, CEO, and Jane Benyamin, CFO/IR, will present the interim report January – June 2025, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below:

If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.

Q2 Report 2025

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

Call Access

Datum 2025-08-21, kl 18:10
Källa MFN
200 kr till alla nya kunder! Just nu får alla nya kunder på Nordnet 200 kronor insatta i fonden Nordnet One Offensiv. Erbjudandet gäller mellan 1:e och 30:e september!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet